562-P: Improved Glycemic and Cardiometabolic Parameters in Type 2 Diabetes Using AI-Enabled Digital Precision Care with Remote Monitoring

Abstract

In India, the average HbA1c in adults with type 2 diabetes is 8.9 ± 2.1% with associated increase in prevalence at 74.2 million is a major challenge in health care sector. Barriers includes insufficient knowledge on self management, medication adherence, emotional disturbances, nutrition and activity guidance and personalized care approach. Studies have suggested remote monitoring using technology, bridges the gap between the patient and health care professionals, at their home and at a lower cost. Use of technology for remote monitoring and personalized guidance in real world settings was evaluated using Credo Health precision care programme. Method: The cohort consists of 72 type 2 diabetes members who enrolled for the diabetes management programme for 3 months at Credo Health. Informed consent was sought from the all the individuals and statistics was applied using GraphPad Prism V-5.0. Results: Significant improvement was achieved at the end of 90 days in mean Glycosylated A1c (Figure 1) (8.7 ± 2.2; 7.2 ± 1.1, p: <0.0001), FPG (172.3 ±73.1; 128.5 ± 37.9, p: <0.001), PPPG (231.8 ± 95.8; 153.8 ± 41.1, p: <0.001), SBP (128.7 ± 18.3; 119.9 ± 11.8, p: <0.001), Serum TGL (206.4 ± 99.9; 161.0 ± 67.27, p: <0.05). Conclusion: Remote monitoring and personalized precision diabetes care management improved glycaemic and cardiometabolic outcomes in 3 months. Disclosure M.Kn: None. B.B: None. A.Khadar: None. D.Mohan: None. M.Mani: None. A.R.Pillai: None. C.S: None. R.Channabasavaiah: None.